DF

David Fink

AP Aventis Pharmaceuticals: 7 patents #11 of 454Top 3%
📍 Lebanon, NJ: #53 of 221 inventorsTop 25%
🗺 New Jersey: #12,389 of 69,400 inventorsTop 20%
Overall (All Time): #749,321 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands James Hendrix, Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Joseph T. Strupczewski +10 more 2010-08-10
7652046 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I Yulin Chiang, Nicola Collar 2010-01-26
7626027 Substituted 1H-pyrrolo[2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase Iε William Metz, Frank Halley, Gilles Dutruc-Rosset, Yong Mi Choi-Sledeski, Gregory Bernard Poli +11 more 2009-12-01
7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands James Hendrix, Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Joseph T. Strupczewski +10 more 2009-04-21
7402672 Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon William Metz, Frank Halley, Gilles Dutruc-Rosset, Yong Mi Choi-Sledeski, Gregory Bernard Poli +11 more 2008-07-22
7393867 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I Yulin Chiang, Nicola Collar 2008-07-01
7186724 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands James Hendrix, Horst Hemmerle, Matthias Urmann, Gregory M. Shutske, Jospeh T Strupczewski +10 more 2007-03-06